Marc Lémann

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

Gert Van Assche, James O. Lindsay, Marc Lémann et al. · Journal of Crohn s and Colitis · 2010 · 1.5K citations

Rheumatology, Anti-tnf Therapy, Adolescent Ibd +9

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

Laurent Beaugerie, Nicole Brousse, Anne‐Marie Bouvier et al. · The Lancet · 2009 · 1.1K citations

Lymphoproliferative Disorders, Gastroenterology, Pathology +4

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

David Laharie, Arnaud Bourreille, Julien Branche et al. · The Lancet · 2012 · 633 citations

Inflammation, Anti-inflammatory, Gastroenterology +4

Risk of tuberculosis is higher with anti–tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three‐year prospective french research axed on tolerance of biotherapies registry

Florence Tubach, Dominique Salmon, Philippe Ravaud et al. · Arthritis & Rheumatism · 2009 · 628 citations · Full text

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Simon Travis, Dan Schnell, Piotr Krzeski et al. · Gut · 2011 · 607 citations · Full text